Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

ORIGINAL ARTICLE

Hippokratia 2014, 18(4):315-318

Vega A, Abad S, Verdalles U, Aragoncillo I, Velazquez K, Quiroga B, Escudero V, LΓ³pez-GΓ³mez JM
Nephrology Department, Hospital General Universitario Gregorio MaraΓ±Γ³n, Madrid, Spain, Internal Medicine, St Columciles Hospital, Dublin, Ireland, Pharmacy Department, Hospital General Universitario Gregorio MaraΓ±Γ³n, Madrid, Spain